首页> 外文OA文献 >Dissolution and solid state behaviours of carbamazepine-gluconolactone solid dispersion powders: The potential use of gluconolactone as dissolution enhancer
【2h】

Dissolution and solid state behaviours of carbamazepine-gluconolactone solid dispersion powders: The potential use of gluconolactone as dissolution enhancer

机译:卡马西平-葡萄糖酸内酯固体分散体粉末的溶解和固态行为:葡萄糖酸内酯作为溶解促进剂的潜在用途

摘要

Solid dispersions are one of the most effective methods for improving the dissolution rate of poorly water-soluble drugs; however, this is reliant on the selection of a suitable carrier and solvent. The present study is the mechanistic evaluation of the changes in polymorphic form of carbamazepine when the type of solvent and the concentration of d-gluconolactone (d-GL) change. The studies reported herein also explore the use of d-GL as a potential hydrophilic carrier to improve the dissolution rate of a poorly water-soluble drug, carbamazepine (CBZ), from physical mixtures and solid dispersion formulations. The effect of using different solvents in the preparation of solid dispersion formulations was also investigated. Different ratios of solid dispersions of the drug and d-GL were prepared using a conventional solvent evaporation method. Different solvents (ethanol, acetone and water) were used as a second experimental variable in the preparation of solid dispersions. Physical mixtures of CBZ and d-GL were also prepared for comparison. The results showed that the presence of d-GL can increase the dissolution rate of CBZ compared to pure CBZ. This study showed that d-GL could be used as a new carrier in solid dispersion formulations and physical mixtures. The interesting solid state behaviour of CBZ in all solid dispersions in the presence of d-GL was fully analyzed using Fourier-transform infrared (FT-IR), X-ray powder diffraction (XRPD), scanning electron microscope (SEM), hot stage microscopy (HSM) and differential scanning calorimetry (DSC). The results showed that depending on the type of solvent and concentration of d-GL used in the preparation of solid dispersions different forms of CBZ (Form I, Form III and dihydrate) can be existed in the formulations
机译:固体分散体是提高水溶性差的药物溶解速度的最有效方法之一。但是,这取决于选择合适的载体和溶剂。本研究是当溶剂类型和d-葡萄糖酸内酯(d-GL)浓度变化时卡马西平多晶型形式变化的机理评估。本文报道的研究还探索了使用d-GL作为潜在的亲水性载体,以改善水溶性差的药物卡马西平(CBZ)从物理混合物和固体分散体制剂中的溶解速率。还研究了在固体分散体制剂中使用不同溶剂的效果。使用常规溶剂蒸发法制备药物和d-GL的固体分散体的不同比例。在制备固体分散体时,将不同的溶剂(乙醇,丙酮和水)用作第二实验变量。还准备了CBZ和d-GL的物理混合物进行比较。结果表明,与纯CBZ相比,d-GL的存在可以提高CBZ的溶解速度。这项研究表明,d-GL可用作固体分散体制剂和物理混合物中的新载体。使用傅立叶变换红外(FT-IR),X射线粉末衍射(XRPD),扫描电子显微镜(SEM),热台分析了d-GL存在下所有固体分散体中CBZ有趣的固态行为显微镜(HSM)和差示扫描量热法(DSC)。结果表明,取决于溶剂的类型和用于制备固体分散体的d-GL的浓度,制剂中可能存在不同形式的CBZ(形式I,形式III和二水合物)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号